![Thierry Chignon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thierry Chignon
Presidente presso AirInSpace SE
Posizioni attive di Thierry Chignon
Società | Posizione | Inizio | Fine |
---|---|---|---|
AirInSpace SE
![]() AirInSpace SE Chemicals: SpecialtyProcess Industries AirInSpace SE develops and manufactures medically effective air decontamination systems for hospital, industrial and residential use. It provides solutions for airborne contaminations. The firm's products include Plasmair, Cool Plasmair, Immunair iso, Plasmair C2010, Biocair IF, and Biocair ML. Its services encompass equipment rentals, service contract, control measures, and training. AirInSpace's proprietary technology, Hepa-MD, also provides particle reduction efficiency and microbial destruction. AirInSpace was founded by Laurent Adrien Fullana in 2002 and is headquartered in Elancourt, France. | Presidente | 23/11/2012 | - |
Mérieux Equity Partners SAS
![]() Mérieux Equity Partners SAS Investment ManagersFinance Mérieux Equity Partners SAS (Mérieux Equity Partners or MxEP) is a Private Equity and Venture Capital firm, a subsidiary of Mérieux Développement SASU founded in 2009. The firm is headquartered in Lyon, France, with additional offices across the country. | Investitore di Private Equity | 01/05/2014 | - |
Seqens SAS
![]() Seqens SAS Pharmaceuticals: MajorHealth Technology Seqens SASU engages in pharmaceutical and healthcare industries. The company was founded on April 2, 2003 and is headquartered in Ecully, France. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Thierry Chignon
Precedenti posizioni note di Thierry Chignon
Società | Posizione | Inizio | Fine |
---|---|---|---|
SUPERSONIC IMAGINE | Direttore/Membro del Consiglio | - | 01/08/2019 |
Matignon Investissement et Gestion SAS
![]() Matignon Investissement et Gestion SAS Investment ManagersFinance Matignon Investissement et Gestion SAS (MIG) is an independent management-owned private equity investment firm based in Paris. MIG was established in 1996 through a management buy-out of Acmer from Banque Worms, formerly part of AXA-UAP and acquired by Deutsche Bank AG in 2001. Following the acquisition, Acmer was delisted. MIG manages private equity and venture capital funds, both generalist and sector specific. | Investitore di Private Equity | 01/11/2006 | 14/06/2014 |
NANOBIOTIX | Direttore/Membro del Consiglio | - | - |
Medicrea SA | Direttore/Membro del Consiglio | - | - |
VISIOMED GROUP SA | Direttore/Membro del Consiglio | 28/04/2011 | - |
Arterial Remodelling Technologies SA
![]() Arterial Remodelling Technologies SA Pharmaceuticals: MajorHealth Technology Arterial Remodelling Technologies SA develops bioresorbable peripheral and coronary polymer stents. Its products includes ART PBS scaffold, procedure and Clinical data. The company was founded by Antoine Lafont, Michel Vert and J. Frederick Cornhill in 2001 and is headquartered in Paris, France. | Direttore/Membro del Consiglio | - | - |
Corporate Officer/Principal | 23/09/2010 | 23/09/2010 |
Formazione di Thierry Chignon
Sciences Po | Masters Business Admin |
École des Hautes Études Commerciales de Paris | Masters Business Admin |
Statistiche
Distribuzione geografica
Francia | 12 |
Posizioni
Director/Board Member | 6 |
Private Equity Investor | 2 |
Masters Business Admin | 2 |
Settori
Health Technology | 7 |
Finance | 3 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
NANOBIOTIX | Health Technology |
VISIOMED GROUP SA | Health Technology |
Aziende private | 7 |
---|---|
Matignon Investissement et Gestion SAS
![]() Matignon Investissement et Gestion SAS Investment ManagersFinance Matignon Investissement et Gestion SAS (MIG) is an independent management-owned private equity investment firm based in Paris. MIG was established in 1996 through a management buy-out of Acmer from Banque Worms, formerly part of AXA-UAP and acquired by Deutsche Bank AG in 2001. Following the acquisition, Acmer was delisted. MIG manages private equity and venture capital funds, both generalist and sector specific. | Finance |
Medicrea SA | Health Technology |
AirInSpace SE
![]() AirInSpace SE Chemicals: SpecialtyProcess Industries AirInSpace SE develops and manufactures medically effective air decontamination systems for hospital, industrial and residential use. It provides solutions for airborne contaminations. The firm's products include Plasmair, Cool Plasmair, Immunair iso, Plasmair C2010, Biocair IF, and Biocair ML. Its services encompass equipment rentals, service contract, control measures, and training. AirInSpace's proprietary technology, Hepa-MD, also provides particle reduction efficiency and microbial destruction. AirInSpace was founded by Laurent Adrien Fullana in 2002 and is headquartered in Elancourt, France. | Process Industries |
SuperSonic Imagine SA
![]() SuperSonic Imagine SA Medical SpecialtiesHealth Technology SuperSonic Imagine SA specializes in ultrasound medical imaging. The company designs, develops and markets a new generation ultrasound system, Aixplorer with an UltraFastTM platform that can acquire images faster than conventional ultrasound systems. Its products are used for general imaging, vascular, hepatology, gastroenterology, and research procedures. It operates under the Aixplorer trademark. SuperSonic Imagine was founded by Jacques Souquet, Armen Sarvazyan, Claude Cohen-Bacrie, Damien Dolimier, Georges Charpak, Jérémy Bercoff, Mickaël Tanter, Mathias Fink and Marianne Leven on March 10, 2005 and is headquartered in Aix-en-Provence, France. | Health Technology |
Seqens SAS
![]() Seqens SAS Pharmaceuticals: MajorHealth Technology Seqens SASU engages in pharmaceutical and healthcare industries. The company was founded on April 2, 2003 and is headquartered in Ecully, France. | Health Technology |
Arterial Remodelling Technologies SA
![]() Arterial Remodelling Technologies SA Pharmaceuticals: MajorHealth Technology Arterial Remodelling Technologies SA develops bioresorbable peripheral and coronary polymer stents. Its products includes ART PBS scaffold, procedure and Clinical data. The company was founded by Antoine Lafont, Michel Vert and J. Frederick Cornhill in 2001 and is headquartered in Paris, France. | Health Technology |
Mérieux Equity Partners SAS
![]() Mérieux Equity Partners SAS Investment ManagersFinance Mérieux Equity Partners SAS (Mérieux Equity Partners or MxEP) is a Private Equity and Venture Capital firm, a subsidiary of Mérieux Développement SASU founded in 2009. The firm is headquartered in Lyon, France, with additional offices across the country. | Finance |
- Borsa valori
- Insiders
- Thierry Chignon
- Esperienza